Wolf‐Rüdiger Ulrich
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Eicosanoids and Hypertension Pharmacology 6
- Oncology 9
- Drug Transport and Resistance Mechanisms 9
- Co-authors
- Volker Gekeler (8 shared papers)W Ise (6 shared papers)James F. Beck (2 shared papers)Karl H. Sanders (2 shared papers)Rainer Boer (13 shared papers)Sabine Haas (5 shared papers)Thomas Klein (2 shared papers)Christian Heßlinger (5 shared papers)
- Journals
- Molecular Pharmacology (6 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Biochemical Society Transactions (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Biochemistry (1 paper)
- Partner nations
- GermanyItalyUnited Kingdom
In The Last Decade
Wolf‐Rüdiger Ulrich
19 papers receiving 838 citations
Peers
Comparison fields: 5 of 94
- Oncology 403
- Biochemistry 90
- Pediatrics, Perinatology and Child Health 171
- Physiology 165
- Toxicology 22
Countries citing papers authored by Wolf‐Rüdiger Ulrich
This map shows the geographic impact of Wolf‐Rüdiger Ulrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolf‐Rüdiger Ulrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolf‐Rüdiger Ulrich more than expected).
Fields of papers citing papers by Wolf‐Rüdiger Ulrich
This network shows the impact of papers produced by Wolf‐Rüdiger Ulrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolf‐Rüdiger Ulrich. The network helps show where Wolf‐Rüdiger Ulrich may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolf‐Rüdiger Ulrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 363 | |
| 2 | 2000 | 143 | |
| 3 | 2009 | 89 | |
| 4 | 2005 | 33 | |
| 5 | 1990 | 30 | |
| 6 | 1996 | 30 | |
| 7 | 2011 | 30 | |
| 8 | 2002 | 29 | |
| 9 | 2001 | 28 | |
| 10 | 1995 | 21 | |
| 11 | 1996 | 17 | |
| 12 | 1996 | 16 | |
| 13 | 2000 | 12 | |
| 14 | 2006 | 11 | |
| 15 | [Reactions of in vitro cultures of human fibroblasts, of HeLa-cells and of murine L-cells on application of a drug from Viscum album L. (author's transl)]. | 1980 | 4 |
| 16 | 1998 | 4 | |
| 17 | 2000 | 4 | |
| 18 | 2002 | 4 | |
| 19 | 1995 | 2 | |
| 20 | 2006 | 1 |
About Wolf‐Rüdiger Ulrich
Wolf‐Rüdiger Ulrich is a scholar working on Biochemistry, Oncology, Biophysics, Physiology and Pharmacology, having authored 20 papers that have together received 871 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Nitric Oxide and Endothelin Effects (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Electron Spin Resonance Studies (4 papers), Cancer therapeutics and mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Oncology (403 citations), Biochemistry (90 citations), Pediatrics, Perinatology and Child Health (171 citations), Physiology (165 citations) and Toxicology (22 citations). Wolf‐Rüdiger Ulrich has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Volker Gekeler, W Ise, James F. Beck, Karl H. Sanders, Rainer Boer, Sabine Haas, Thomas Klein, Christian Heßlinger, Andreas Strub and Martin D. Lehner. Their work appears in journals such as Molecular Pharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology, Biochemical Society Transactions, Journal of Pharmacology and Experimental Therapeutics and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.